drugset / Trial / NCT00553124

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

NCT00553124

Phase 3 Unknown 3400 enrolled University Hospital Birmingham
Prevention

Summary

RATIONALE: Studying different factors that effect patients with newly diagnosed bladder cancer may help doctors learn more about the disease, improve the ability to plan cancer treatment, and help patients live more comfortably. PURPOSE: This clinical trial is studying different factors affecting patients with newly diagnosed bladder cancer.

Timeline

Start
2005-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Selenium Other / unclassified
Subject Vitamin E Other / unclassified